{"name":"Alexandria Real Estate Equities","permalink":"alexandria-real-estate-equities","crunchbase_url":"http://www.crunchbase.com/financial-organization/alexandria-real-estate-equities","homepage_url":"http://www.labspace.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"626-396-4828","description":"","email_address":"corporateinformation@labspace.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Fri May 22 21:44:50 UTC 2009","updated_at":"Sat Jul 11 04:01:45 UTC 2009","overview":"<p>Alexandria Real Estate Equities, Inc., Landlord of Choice to the Life Science IndustryÂ®, is the largest owner and pre-eminent first-in-class real estate investment trust focused principally on science-driven cluster formation. Alexandria is the leading provider of real estate to the life science industry, and has an outstanding 11 year track record as a NYSE listed company with an approximate $5.2 billion total market capitalization (as of December 31, 2008). </p>","image":{"available_sizes":[[[150,52],"assets/images/resized/0005/2582/52582v2-max-150x150.jpg"],[[235,82],"assets/images/resized/0005/2582/52582v2-max-250x250.jpg"],[[235,82],"assets/images/resized/0005/2582/52582v2-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"385 E. Colorado Blvd.","address2":"Suite 299","zip_code":"91101","city":"Pasadena","state_code":"CA","country_code":"USA","latitude":34.146227,"longitude":-118.142269}],"relationships":[],"investments":[{"funding_round":{"round_code":"b","source_url":"http://www.venturedeal.com/News/2008/4/21/BrainCells-Secures-$20-Million-More-Series-B-Funding","source_description":"BrainCells Secures $20 Million More Series B Funding","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":4,"funded_day":1,"company":{"name":"BrainCells","permalink":"braincells","image":{"available_sizes":[[[150,61],"assets/images/resized/0004/3268/43268v1-max-150x150.png"],[[191,78],"assets/images/resized/0004/3268/43268v1-max-250x250.png"],[[191,78],"assets/images/resized/0004/3268/43268v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://deals.venturebeat.com/2009/11/09/cambrios-lands-14-5m-for-electronic-display-components/","source_description":"Cambrios lands $14.5M for electronic display components","raised_amount":14500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":1,"company":{"name":"Cambrios Technologies","permalink":"cambrios-technologies","image":{"available_sizes":[[[150,50],"assets/images/resized/0006/5475/65475v1-max-150x150.jpg"],[[198,67],"assets/images/resized/0006/5475/65475v1-max-250x250.jpg"],[[198,67],"assets/images/resized/0006/5475/65475v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/metabolon-inc-series-c-6m/","source_description":"Metabolon, Inc.: Series C $6M","raised_amount":6000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":7,"company":{"name":"Metabolon","permalink":"metabolon","image":{"available_sizes":[[[150,26],"assets/images/resized/0006/8827/68827v1-max-150x150.png"],[[190,34],"assets/images/resized/0006/8827/68827v1-max-250x250.png"],[[190,34],"assets/images/resized/0006/8827/68827v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://ceruleanrx.com/Press/CeruleanPressRelease_010308.pdf","source_description":"Tempo Pharmaceuticals Closes $8 Million in Series B Funding","raised_amount":8100000,"raised_currency_code":"USD","funded_year":2008,"funded_month":1,"funded_day":3,"company":{"name":"Cerulean Pharma","permalink":"cerulean","image":{"available_sizes":[[[150,46],"assets/images/resized/0005/4532/54532v2-max-150x150.jpg"],[[250,77],"assets/images/resized/0005/4532/54532v2-max-250x250.jpg"],[[279,86],"assets/images/resized/0005/4532/54532v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.allbusiness.com/company-activities-management/board-management-changes/5299825-1.html","source_description":"Allozyne, Inc., Closes $30 Million Series B Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":26,"company":{"name":"Allozyne","permalink":"allozyne","image":{"available_sizes":[[[143,150],"assets/images/resized/0008/0052/80052v1-max-150x150.jpg"],[[239,250],"assets/images/resized/0008/0052/80052v1-max-250x250.jpg"],[[244,255],"assets/images/resized/0008/0052/80052v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.xconomy.com/seattle/2010/04/29/accelerators-mirina-nabs-3-9m/","source_description":"Mirina Nabs $3.9M","raised_amount":3900000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":26,"company":{"name":"Mirina","permalink":"mirina","image":{"available_sizes":[[[150,113],"assets/images/resized/0008/4992/84992v1-max-150x150.png"],[[250,189],"assets/images/resized/0008/4992/84992v1-max-250x250.png"],[[250,189],"assets/images/resized/0008/4992/84992v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.xconomy.com/seattle/2010/03/19/theraclone-raises-1-5m/","source_description":"Theraclone Raises $1.5M","raised_amount":1500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":17,"company":{"name":"Theraclone Sciences","permalink":"theraclone-sciences","image":{"available_sizes":[[[150,32],"assets/images/resized/0009/4651/94651v1-max-150x150.jpg"],[[250,54],"assets/images/resized/0009/4651/94651v1-max-250x250.jpg"],[[305,67],"assets/images/resized/0009/4651/94651v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"","source_description":"Cap Funding Report","raised_amount":41500000,"raised_currency_code":"USD","funded_year":2005,"funded_month":11,"funded_day":9,"company":{"name":"nanosys","permalink":"nanosys","image":{"available_sizes":[[[150,32],"assets/images/resized/0009/6895/96895v3-max-150x150.png"],[[250,53],"assets/images/resized/0009/6895/96895v3-max-250x250.png"],[[450,97],"assets/images/resized/0009/6895/96895v3-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/acylin-therapeutics-inc-series-a-44m/","source_description":"Acylin Therapeutics, Inc.: Series A $4.4M","raised_amount":4400000,"raised_currency_code":"USD","funded_year":2011,"funded_month":1,"funded_day":11,"company":{"name":"Acylin Therapeutics","permalink":"acylin-therapeutics","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/oncofactor-inc-series-a-21m/","source_description":"Oncofactor, Inc.: Series A $2.1M","raised_amount":2100000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":2,"company":{"name":"Oncofactor Corporation","permalink":"oncofactor-corporation","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://www.masshightech.com/stories/2007/06/11/daily6-Nutmeg-State-biotech-lands-258M-in-round-one.html","source_description":"Nutmeg State biotech lands $25.8M in round one","raised_amount":25800000,"raised_currency_code":"USD","funded_year":2007,"funded_month":6,"funded_day":11,"company":{"name":"BioRelix","permalink":"biorelix","image":{"available_sizes":[[[150,70],"assets/images/resized/0011/5274/115274v1-max-150x150.png"],[[155,73],"assets/images/resized/0011/5274/115274v1-max-250x250.png"],[[155,73],"assets/images/resized/0011/5274/115274v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}